Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2675

Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2006;113:2675.)
© 2006 American Heart Association, Inc.

Issue Highlights


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    SINGLE-GENE MUTATIONS AND INCREASED LEFT VENTRICULAR WALL THICKNESS IN THE COMMUNITY: THE FRAMINGHAM HEART STUDY, by Morita et al.
 
Left ventricular hypertrophy (LVH) is associated with stroke, coronary heart disease, heart failure, and cardiovascular and all-cause mortality. LVH results from increases in LV wall thickness (LVWT), LV mass, and LV volume. Unexplained increases in LVWT (LVWT 13mm) contribute to LVH in 3% of the general population over the age of 45. Mutations in sarcomere protein, PRKAG2, LAMP2, {alpha}-galactosidase A (GLA), and several mitochondrial genes are associated with rare familial cardiomyopathies; their contribution to LVH in the community is unknown, however. Morita et al identified the prevalence and clinical features of single-gene mutations in adults in the community with increased LVWT in the absence of obvious secondary forms of hypertrophy. Among 1862 Framingham Heart Study participants, 50 had unexplained increased LVWT. Eight subjects (16%) had sarcomere protein gene mutations and one (2%) had a GLA mutation. Therefore, approximately 0.5% of the general population over age 45 has increased unexplained LVWT and a single-gene mutation that probably accounts for their hypertrophy. Increased LVWT in the community is a heterogeneous condition, and additional investigation of the prevalence and clinical features of single-gene mutations in other community-based cohorts will help improve our understanding of the broad spectrum of genetic causes of increased LVWT. See p 2697.


*    AEROBIC CAPACITY IN PATIENTS ENTERING CARDIAC REHABILITATION, by Ades et al.
 
Exercise training is a key component of comprehensive cardiac rehabilitation/secondary prevention programs and generally yields marked improvements in exercise capacity, particularly among those with the lowest initial fitness levels. In this issue of Circulation, Ades et al provide normative values for . . . [Full Text of this Article]


Related Articles:

Large Renal Artery Aneurysm Treated With Stent Graft
Muzaffer Degertekin, Fatih Bayrak, Bulent Mutlu, Bengi Gürses, Salih Güran, and Ertan Demirtas
Circulation 2006 113: e848-e849. [Extract] [Full Text]

Severe Endothelial Dysfunction After Sirolimus-Eluting Stent Implantation
Kiyoaki Maekawa, Kenji Kawamoto, Soichiro Fuke, Ryo Yoshioka, Hironori Saito, Tetsuya Sato, and Toru Hioka
Circulation 2006 113: e850-e851. [Extract] [Full Text]

A 54-Year-Old Woman With Chest Pain, Dyspnea, and Inferior Injury on Electrocardiography
Joseph M. Szczytowski, Timothy A. Mixon, Raul A. Santos, and Mark E. Lawrence
Circulation 2006 113: e852. [Extract] [Full Text]

Molecular Mechanisms of Cardiac Hypertrophy and Failure
Beverly A. Rothermel and Joseph A. Hill
Circulation 2006 113: e853. [Extract] [Full Text]

Letter by Lehmann Regarding Articles "Electrocardiographic Abnormalities That Predict Coronary Heart Disease Events and Mortality in Postmenopausal Women: The Women’s Health Initiative" and "Electrocardiographic Predictors of Incident Congestive Heart Failure and All-Cause Mortality in Postmenopausal Women: the Women’s Health Initiative"
Michael H. Lehmann
Circulation 2006 113: e854. [Extract] [Full Text]

Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study
Alan S. Go, Jingrong Yang, Lynn M. Ackerson, Krista Lepper, Sean Robbins, Barry M. Massie, and Michael G. Shlipak
Circulation 2006 113: 2713-2723. [Abstract] [Full Text]

Single-Gene Mutations and Increased Left Ventricular Wall Thickness in the Community: The Framingham Heart Study
Hiroyuki Morita, Martin G. Larson, Scott C. Barr, Ramachandran S. Vasan, Christopher J. O’Donnell, Joel N. Hirschhorn, Daniel Levy, Diane Corey, Christine E. Seidman, J.G. Seidman, and Emelia J. Benjamin
Circulation 2006 113: 2697-2705. [Abstract] [Full Text]

Aerobic Capacity in Patients Entering Cardiac Rehabilitation
Philip A. Ades, Patrick D. Savage, Clinton A. Brawner, Caroline E. Lyon, Jonathan K. Ehrman, Janice Y. Bunn, and Steven J. Keteyian
Circulation 2006 113: 2706-2712. [Abstract] [Full Text]